Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds (Q26825916)

Jolien Bridelance

series ordinal

2

1 reference

Ilse M. Beck

series ordinal

5

1 reference

language of work or name

1 reference

August 2015

1 reference

Pharmacology & Therapeutics

published in

1 reference

volume

152

1 reference

page(s)

28-41

1 reference

Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts

cites work

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective glucocorticoid receptor modulation maintains bone mineral density in mice

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The possible separation of 12‐O‐tetradecanoylphorbol‐13‐acetate‐induced skin inflammation and hyperplasia by compound A

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

New Glucocorticosteroids with an improved therapeutic ratio?

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Discovery of selective glucocorticoid receptor modulator MK-5932

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Targeting inflammation using selective glucocorticoid receptor modulators

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Crosstalk between TNF and glucocorticoid receptor signaling pathways

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Dominance of the strongest: inflammatory cytokines versus glucocorticoids

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Anti-inflammatory glucocorticoids: changing concepts

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Update on glucocorticoid action and resistance

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective Glucocorticoid Receptor modulators

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Current concepts in glucocorticoid resistance

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid receptor concentration and the ability to dimerize influence nuclear translocation and distribution

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Mechanisms involved in the side effects of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Drug insight: selective agonists and antagonists of the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Genomic and nongenomic effects of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Principles for modulation of the nuclear receptor superfamily

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid sensitivity in health and disease

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The multiple facets of glucocorticoid action in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Cross-talk between nuclear receptors and nuclear factor kappaB.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

A fully dissociated compound of plant origin for inflammatory gene repression

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Roles for the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, in feedback control of inflammatory gene expression and repression by dexamethasone.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid-Dependent Transcriptional Repression of the Osteocalcin Gene by Competitive Binding at the TATA Box

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Importin-7 mediates glucocorticoid receptor nuclear import and is impaired by oxidative stress, leading to glucocorticoid insensitivity

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Interactions between the heat shock response and the nuclear factor-kappa B signaling pathway

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The epidemiology of glucocorticoid-associated adverse events

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Mode of glucocorticoid actions in airway disease.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticosteroids: current and future directions

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

On the Trail of the Glucocorticoid Receptor: Into the Nucleus and Back

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Ligand-Independent Phosphorylation of the Glucocorticoid Receptor Integrates Cellular Stress Pathways with Nuclear Receptor Signaling

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The origin and functions of multiple human glucocorticoid receptor isoforms

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Steroid-mediated regulation of the epithelial sodium channel subunits in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoids induce gastroparesis in mice through depletion of l-arginine

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

The search for safer glucocorticoid receptor ligands

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Comprehensive overview of the structure and regulation of the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid receptor phosphorylation differentially affects target gene expression

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells.

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitro

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture model

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Regulation of inflammatory cell function by corticosteroids

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNK

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Glucocorticoid Analogues: Potential Therapeutic Alternatives for Treating Inflammatory Muscle Diseases

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

A Dissociated Glucocorticoid Receptor Modulator Reduces Airway Hyperresponsiveness and Inflammation in a Mouse Model of Asthma

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021

A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2015.05.001

7 January 2021